Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Learn various ways to maximize your cash savings and improve your financial future. Start implementing these strategies now.
20,570 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
As crypto markets swing, STRC's flagship preferred shares are drawing more attention from everyday investors. This pi...
In a dramatic Q1, a bold Bitcoin-focused strategy posts a $12.5 billion loss. This article explains what happened, wh...
NVIDIA led the AI chip boom, but growing competition and supply forces may erode its edge. This guide breaks down the...
As Nvidia prepares to report earnings in May, investors weigh AI momentum against valuation. This practical guide exp...
Palantir posted solid Q1 2026 growth, but the stock fell as investors priced in a valuation reset and AI competition....
Realty Income raised dividend for the 113th consecutive time, but the stock trades at rich valuations with rising lev...
Domain Money is expanding as investors seek integrated, CFP-guided planning powered by AI tools amid market volatilit...
Nordson (NDSN) is set for a pivotal 2025 earnings year. This guide breaks down the levers that could move profits, ho...
Retail investors push Ford into meme-stock territory as Wall Street holds, sparking a heated debate about the automak...
Two retail giants dominate the home improvement space as 2026 unfolds. This guide digs into Lowe's and The Home Depot...
Strategy transferred 411.48 BTC to Coinbase on May 29, 2026, a tiny slice of its huge stake. The move sparks renewed ...